10-K Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001213900-24-024013`
Period End Date	20231231
Filing Date	20240319
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	f10k2023_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 55 Income Statement 28 Cash Flow Statement 55 Stockholders Equity 18

Balance Sheet 55 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.09M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.40M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$142.93M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$92.23M	USD	Point-in-time
Other receivables	`ReceivablesNetCurrent`	-	USD	Point-in-time
Other receivables	`ReceivablesNetCurrent`	$512.43K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$1.19M	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$97.51M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$152.87M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$34.88K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$43.12K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total assets	`Assets`	$97.55M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Total assets	`Assets`	$152.91M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.51M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.10M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$5.26M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.21M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.10M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.47M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.19M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.47M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.19M	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 and 30,099,203 shares issued and outstanding, respectively	`CommonStockValue`	$30.10K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 30,099,203 and 30,099,203 shares issued and outstanding, respectively	`CommonStockValue`	$30.10K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$602.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$646.23M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-462.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-560.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$140.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$85.36M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$208.26M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$152.91M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$97.55M	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net loss per common share Diluted	`EarningsPerShareDiluted`	$-5.30	USD	Annual
Net loss per common share Diluted	`EarningsPerShareDiluted`	$-3.28	USD	Annual
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.63M	shares	Annual
Research and development	`ResearchAndDevelopmentExpense`	$54.81M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$113.32M	USD	Annual
Weighted average number of common shares outstanding Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.10M	shares	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$48.89M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$47.93M	USD	Annual
Total operating expenses	`OperatingExpenses`	$161.25M	USD	Annual
Total operating expenses	`OperatingExpenses`	$103.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-103.70M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-161.25M	USD	Annual
Gain on settlement of fees	`GainOnSettlementOfFees`	$6.35M	USD	Annual
Gain on settlement of fees	`GainOnSettlementOfFees`	-	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$2.66M	USD	Annual
Interest/investment income, net	`InterestIncomeExpenseNet`	$5.15M	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-585.52K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-4.06M	USD	Annual
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$3.82M	USD	Annual
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnInvestments`	$-4.22M	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$4.21M	USD	Annual
Total other income (expenses), net	`NonoperatingIncomeExpense`	$4.91M	USD	Annual
Net loss	`NetIncomeLoss`	$-98.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-5.30	USD	Annual
Net loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-3.28	USD	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.10M	shares	Annual
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.63M	shares	Annual

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-98.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$43.81M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$44.19M	USD	Annual
Gain on settlement	`GainOnSettlement`	$6.35M	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-585.52K	USD	Annual
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-4.06M	USD	Annual
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$3.82M	USD	Annual
Unrealized (gain) loss on short-term investments	`UnrealizedGainLossOnInvestments`	$-4.22M	USD	Annual
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-86.38K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-512.43K	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$512.43K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-7.26M	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-2.84M	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$421.04K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.76M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$3.34M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.48M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-51.66M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-103.80M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$90.46M	USD	Annual
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$47.29M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$67.03M	USD	Annual
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$140.92M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$19.73M	USD	Annual
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$50.45M	USD	Annual
Payment of ATM fees	`PaymentsOfFinancingCosts`	-	USD	Annual
Payment of ATM fees	`PaymentsOfFinancingCosts`	$98.46K	USD	Annual
Payment of fees for warrants issued for common stock	`ProceedsFromPaymentOfFeesForWarrantsIssuedForCommonStock`	$-50.00K	USD	Annual
Payment of fees for warrants issued for common stock	`ProceedsFromPaymentOfFeesForWarrantsIssuedForCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$52.70K	USD	Point-in-time
Proceeds from options exercised for common stock	`ProceedsFromStockOptionsExercised`	$703.72K	USD	Annual
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	$1.26M	USD	Annual
Proceeds from warrants exercised for common stock	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from short swing profit, net	`ProceedFromShortSwingProfitNet`	-	USD	Annual
Proceeds from short swing profit, net	`ProceedFromShortSwingProfitNet`	$373.63K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-98.46K	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$45.02M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-39.05M	USD	Annual
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.30M	USD	Annual
Cash and cash equivalents at beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.44M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.40M	USD	Point-in-time
Cash and cash equivalents at beginning of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.09M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.40M	USD	Point-in-time
Cash and cash equivalents at end of the year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.09M	USD	Point-in-time
Forgiveness of accounts payable related to gain	`ForgivenessOfAccountsPayableRelatedToGain`	$3.21M	USD	Annual
Forgiveness of accounts payable related to gain	`ForgivenessOfAccountsPayableRelatedToGain`	-	USD	Annual
Share exchange for Pre-funded warrants	`ShareExchangeForPrefundedWarrants`	$1.45K	USD	Annual
Share exchange for Pre-funded warrants	`ShareExchangeForPrefundedWarrants`	-	USD	Annual
Net exercise of Pre-funded warrants	`NetExerciseOfPrefundedWarrants`	$-1.45K	USD	Annual
Net exercise of Pre-funded warrants	`NetExerciseOfPrefundedWarrants`	-	USD	Annual

Stockholders Equity 18 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$43.81M	USD	Annual
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$44.19M	USD	Annual
ATM offering, net	`StockIssuedDuringPeriodValueOther`	$-98.46K	USD	Annual
ATM offering, net	`StockIssuedDuringPeriodValueOther`	$42.73M	USD	Annual
Share exchange -Prefunded warrants, net of fees	`StockIssuedDuringPeriodValueShareExchangePrefundedWarrantsNetOfFees`	$-50.00K	USD	Annual
Net exercise -Prefunded warrants	`StockIssuedDuringPeriodValueNetExercisePrefundedWarrants`	-	USD	Annual
Warrants exercised	`AdjustmentsToAdditionalPaidInCapitalWarrantsExercised`	$1.26M	USD	Annual
Options exercised	`StockIssuedDuringPeriodValueStockOptionsExercised`	$703.72K	USD	Annual
Options exercised (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	83,698.00	shares	Annual
Short swing profit, net	`StockIssuedDuringPeriodValueShortSwingProfitNet`	$373.63K	USD	Annual
Net loss	`NetIncomeLoss`	$-98.79M	USD	Annual
Net loss	`NetIncomeLoss`	$-157.04M	USD	Annual
Balance	`StockholdersEquity`	$140.44M	USD	Point-in-time
Balance	`StockholdersEquity`	$85.36M	USD	Point-in-time
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.